Companies: 10,795·Total market cap: $144.5T
Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc.

FNAMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1331
P/E Ratio—
52W High$0.45
52W Low$0.0002
SEC Filings

Evolutionary Genomics, Inc. (FNAM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000884363 · FNAM · OTC · as of Jun 9, 2026

Filing snapshot

130
Total Filings
15-12G
Latest Form
2023-04-28
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000884363 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-09
Fiscal Year End
Mar 9, 2023
Accession No.
0001553350-23-000160
Primary Document
fnam_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000884363 · Accession 0001553350-23-000160

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2022-10-21
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2022-03-31Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
FORM 15
2023-04-28
View
10-KAnnual Report
ANNUAL REPORT
2023-03-09
View
10-QQuarterly Report
QUARTERLY REPORT
2022-10-21
View
10-QQuarterly Report
QUARTERLY REPORT
2022-08-08
View
10-QQuarterly Report
QUARTERLY REPORT
2022-05-16
View
DD
D
2022-05-12
View
8-KCurrent Report
CURRENT REPORT
2022-03-31
View
10-KAnnual Report
ANNUAL REPORT
2022-03-22
View
10-QQuarterly Report
QUARTERLY REPORT
2021-11-01
View
10-QQuarterly Report
QUARTERLY REPORT
2021-08-06
View
10-QQuarterly Report
QUARTERLY REPORT
2021-05-13
View
10-KAnnual Report
ANNUAL REPORT
2021-03-31
View
10-QQuarterly Report
QUARTERLY REPORT
2020-11-13
View
10-QQuarterly Report
QUARTERLY REPORT
2020-08-19
View
NT 10-QNT 10-Q
NOTIFICATION OF LATE FILING
2020-08-14
View
Showing 1–15 of 117 filingsForm 4 / 144 hidden· 130 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000884363  |  Exchange: OTC · Healthcare

Evolutionary Genomics, Inc. (OTC: FNAM) has submitted 130 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0000884363, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Evolutionary Genomics, Inc.'s most comprehensive regulatory disclosure. The most recent Evolutionary Genomics, Inc. 10-K was filed on 2023-03-09 for fiscal year ending 2023. Historical FNAM 10-K annual reports are available from 2010 through 2023.

Investors researching Evolutionary Genomics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
HLYK SEC Filings →ENZN SEC Filings →RSCF SEC Filings →TDSGF SEC Filings →LIFD SEC Filings →DOSEF SEC Filings →SRNE SEC Filings →SIGY SEC Filings →
→ FNAM Financials→ FNAM Earnings→ FNAM Insider Trades

Frequently Asked Questions

FNAM SEC Filings · 8 questions

Evolutionary Genomics, Inc. (FNAM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 130 filings and access original documents at no cost. Evolutionary Genomics, Inc.'s CIK is 0000884363.

FNAM SEC filingsEvolutionary Genomics, Inc. SEC documentsfind FNAM 10-K